Clinical Trials
4 trialsNCT04728425 2025-04-27
MG_SCIG
University Health Network, Toronto
Phase 2 Completed
NCT02774239 2023-02-21
SCIG-MG
University of Alberta
Phase 3 Completed
NCT02100969 2021-06-02
Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis
University of Kansas Medical Center
Phase 2 Completed
NCT01828294 2019-04-03
SIMM
St. Louis University
Phase 1 Terminated